Genprex, Inc. GNPX
1.90 USD -0.18 (-8.65%)
Regular-session close
1.90 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
1.83 Day range 2.14
1.71 52-week range 98.76
- YTD
- -95.06%
- 1 year
- -98.05%
News
prnewswire.com Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium Genprex Senior Director of Quality Control & Product Development to Present Insights from Parallel AAV and Lipid-Based Development Programs Presentation to Highlight Drug Development, Manufacturing…benzinga.com Genprex Highlights New Peer-Reviewed Research In Mice Identifying Important Role For TUSC2 Tumor Suppressor Gene In Maintaining Cellular Processes Associated With Healthy Brain Aging Collaborators publish new peer-reviewed study identifying sex-specific effects of TUSC2 loss on mitochondrial function, protein homeostasis, and synaptic pathways, alongside molecular similarities…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 11.0% to $0.17 during Friday's after-market session. The company's market cap stands at $2.4 million. Lexaria Bioscience…
